20 research outputs found

    TCD4pos lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agents

    Get PDF
    BACKGROUND: Lymphocyte expansion and true lymphocytosis are commonly observed in the everyday clinical practice. The meaning of such phenomenon is often poorly understood so that discrimination between benign and malignant lymphocytosis remains difficult to establish. This is mainly true when lymphocytosis rises in patients affected by immune-mediated chronic inflammatory diseases under immunosuppressive treatment, conditions potentially associated with lymphomagenesis. In this brief report the development of mild T CD4pos lymphocytosis in a group of patients with chronic arthritis under anti-TNF-α treatment is described. METHODS: Two hundred eight rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients have been evaluated longitudinally for at least 1-year before and 2-years after anti-TNF-α therapy introduction for the possible appearance of a lymphocyte expansion. In patients who developed lymphocyte expansion, T, B and NK cells were analysed. RESULTS: Twenty-five out of 208 (12%) subjects developed a mild T CD4pos lymphocytosis, during anti-TNF-α therapy, which reverted after its interruption. Higher lymphocyte count, more frequent use of steroids and shorter disease duration, before biological therapy start, have emerged as risk factors for lymphocytosis development. CONCLUSIONS: This is the first longitudinal cohort study evaluating the onset of lymphocytosis in RA and PsA patients under anti-TNF-α treatment and its possible clinical relevance. A mild T CD4pos lymphocytosis has been observed in 12% of RA and PsA patients probably related to anti-TNF-α treatment as previously reported by anecdotal cases. Patients with higher baseline lymphocyte count, use of steroids and shorter disease duration before the introduction of biologic therapy, seem to be prone to develop this laboratory reversible abnormality

    The Influence of Body Armor on Balance and Movement Quality

    Get PDF
    International Journal of Exercise Science 11(1): 648-656, 2018. Body armor is essential to the protection of military personnel; however, body armor may impede the users balance and movement quality. A better understanding of the influence of body armor on balance and movement quality may help in the development of new guidelines for training standards and procedures to mitigate the risk of injury associated with wearing of body armor in warfighters. The purpose of this study was to identify the effects of body armor (combat boots, tactical vest and combat helmet) on balance and movement quality in male military cadets and personnel. Twelve male participants completed the Functional Movement Screen (FMS) and Star Excursion Balance Test (SEBT) under two separate conditions, body armor and non-body armor. Results indicated a significant difference in FMS composite score between the non-body armor and body armor conditions (p =.012), with the non-body armor condition resulting in significantly higher FMS scores than the body armor condition. Additionally, the FMS item score for shoulder mobility was significantly higher (2.25±0.62) in the non-body armor condition than the body armor condition (p= 0.03). The SEBT composite and the three individual reach distances were not significantly different between conditions. Based on the current findings, body armor within a 4.8 kg – 5.3 kg range does appear to impact movement quality as evaluated using the FMS in male military personnel and cadets. More research is needed to determine a threshold of compensatory movement patterns relative to an increase in body armor weight
    corecore